Please login to the form below

Not currently logged in
Email:
Password:

EFPIA

This page shows the latest EFPIA news and features for those working in and with pharma, biotech and healthcare.

Biopharma industry encouraged by EMA’s COVID-19 transparency measures

Biopharma industry encouraged by EMA’s COVID-19 transparency measures

The International Federation of Pharmaceutical Manufacturers &Associations (IFPMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) have welcomed the European Medicines Agency’s (EMA) new COVID-19 initiative.

Latest news

More from news
Approximately 35 fully matching, plus 154 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 6 fully matching, plus 33 partially matching documents found.

Latest appointments

  • EFPIA appoints Hubertus von Baumbach as president EFPIA appoints Hubertus von Baumbach as president

    Von Baumbach will serve as president of the EFPIA for the next two years. ... Commenting on his appointment as president of the EFPIA, von Baumbach said: “The pandemic has severely tested European health and economic resilience.

  • EFPIA appoints new director general EFPIA appoints new director general

    Joe Jiminez, president of EFPIA, said: “Nathalie has an excellent track record of leadership and engagement across the life science sector. ... We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges

  • IFPMA appoints director general IFPMA appoints director general

    Thomas Cueni brings expertise from Interpharma and EFPIA. The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has selected Thomas Cueni as its new director general. ... Cueni also brings industry expertise from the

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    He also brings branding and sales leadership experience from Novar tis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.

  • Eric Cornut appointed EFPIA interim director general Eric Cornut appointed EFPIA interim director general

    Currently an independent consultant based in Basel, Switzerland, Cornut brings over 25 years of pharmaceutical management experience to the role, including five years as chairman of EFPIA's executive committee. ... work. “I am very pleased that Eric

More from appointments
Approximately 7 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • EU Pharmaceutical Strategy Roadmap EU Pharmaceutical Strategy Roadmap

    It seems that in the Roadmap, the Commission has responded to calls from industry, including the European Federation of Pharmaceutical Industries and Federations (EFPIA) and the European Confederation of Pharmaceutical Entrepreneurs

  • The changing face of medical communications over the past 15 years

    Similarly, the launch of Disclosure UK’s searchable database, which went live in June 2016, is a helpful development for the UK (and Europe-wide through EFPIA), although details don’t

  • How Transparent Is Transparency?

    So, what have we learnt? Is the  EFPIA  mission – to provide a greater understanding of the merits and ethics of the interactions between pharmaceutical companies and healthcare professionals (HCPs) – bearing any ... The EFPIA vision of enhanced

  • Compliance Hub Ltd

    Specialists in ABPI, ABHI and EFPIA codes of practice - provides training, audit and consultancy services.

  • Cameron Medical Communications Ltd

    We specialise in: Marketing Codes of Practice, ABPI, EFPIA, IFPMA, Medical Information Systems and Services and Copyright.

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...
Personalised medicine AI
How early-stage clinical research is facilitating the new wave of personalised medicines
By Jorg Taubel...
patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...